← Back to Clinical Trials
Recruiting NCT06011018

NCT06011018 Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06011018
Status Recruiting
Phase —
Sponsor Kaohsiung Medical University Chung-Ho Memorial Hospital
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2022-10-25
Primary Completion 2026-07-31

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Mirror TherapyMirror Therapy + Electrical StimulationMirror Therapy + Binaural Beat

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 72 participants in total. It began in 2022-10-25 with a primary completion date of 2026-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the effects of mirror therapy combined with either neuromuscular electrical stimulation or binaural beat stimulation on post-stroke lower limb motor function recovery. The study also explores the relationship between patients' cortical excitability and motor function improvement.

Eligibility Criteria

Inclusion Criteria: 1. First occurrence of stroke≧ 6 months 2. Mini-mental state examination≧24 3. Modified Ashworth's scale of ankle muscle ≦3 4. Sit independently≧30 mins 5. Brunnstrom stage ≧3 6. Aged between 20 and 80 years Exclusion Criteria: 1. Speech impairment 2. Hearing impairment 3. Visual impairment 4. Other orthopedic diseases or nerve damage 5. Complete sensory impairment 6. Pacemaker or metal implants

Contact & Investigator

Central Contact

LIN JAU HONG, Ph.D.

✉ jhlin@kmu.edu.tw

📞 0929393300

Principal Investigator

LIN JAU HONG, Ph.D.

STUDY CHAIR

Kaohsiung Medical University,department of Physical Therapy

Frequently Asked Questions

Who can join the NCT06011018 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06011018 currently recruiting?

Yes, NCT06011018 is actively recruiting participants. Contact the research team at jhlin@kmu.edu.tw for enrollment information.

Where is the NCT06011018 trial being conducted?

This trial is being conducted at Kaohsiung City, Taiwan.

Who is sponsoring the NCT06011018 clinical trial?

NCT06011018 is sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. The principal investigator is LIN JAU HONG, Ph.D. at Kaohsiung Medical University,department of Physical Therapy. The trial plans to enroll 72 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology